Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
Status:
Completed
Trial end date:
2019-03-05
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of rosuvastatin/ezetimibe combination therapy compared to
rosuvastatin monotherapy in Korean patients with type 2 diabetes mellitus and
hypercholesterolemia